To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Greater Cincinnati startup ...

CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), announced ...

CINCINNATI (WKRC) - A company in Evendale is changing medicine through a breakthrough device that gives patients a way to take certain medications at home. Its purpose is to redefine drug delivery.

Collaboration underscores both companies’ commitment to advancing patient-centric solutions and expanding access to therapies through novel drug delivery technologies Under the terms of the agreement, ...

Enable Injections, maker of manual and connected adhesive wearables for subcutaneously therapeutic delivery, has raised $50 million in a Series B round led by Sanofi, the company announced today. ORI ...

CINCINNATI, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System, today announced ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cincinnati’s top venture ...

CINCINNATI, May 07, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse ® platform of wearable drug delivery device technology, ...

CINCINNATI, March 5, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse ® platform of wearable technology, today announced that ...

Under the terms of the agreement, Incyte will obtain a worldwide, exclusive license to use the enFuse technology with its mutCALR-targeted therapy (INCA033989) in essential thrombocythemia (ET) and ...